{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:35:13Z","timestamp":1777988113705,"version":"3.51.4"},"reference-count":48,"publisher":"Sociedade Brasileira de Cardiologia","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"DOI":"10.36660\/abc.20250116","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:45:04Z","timestamp":1770407104000},"source":"Crossref","is-referenced-by-count":0,"title":["Preval\u00eancia e Caracteriza\u00e7\u00e3o do Fen\u00f3tipo de Cardiomiopatia Hipertr\u00f3fica Avaliado por Ecocardiografia em uma Popula\u00e7\u00e3o Adulta Brasileira: O Estudo ELSA-Brasil"],"prefix":"10.36660","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1382-5277","authenticated-orcid":false,"suffix":"Filho","given":"Amadeu Antonio","family":"Bertuol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre da Costa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-0547","authenticated-orcid":false,"given":"Angela Barreto Santiago","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-0042","authenticated-orcid":false,"given":"Antonio Luiz Pinho","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce Bartholow","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Gatti","family":"Pianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Luis","family":"Scolari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2914-4406","authenticated-orcid":false,"given":"Murilo","family":"Foppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"10","key":"key20260206194459_B1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular Genetic Basis of Hypertrophic Cardiomyopathy","volume":"128","author":"Marian","year":"2021","unstructured":". Marian AJ. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Circ Res. 2021;128(10):1533-53. doi: 10.1161\/CIRCRESAHA.121.318346.","journal-title":"Circ Res"},{"issue":"3","key":"key20260206194459_B2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12574-020-00467-9","article-title":"The Role of Echocardiography for Diagnosis and Prognostic Stratification in Hypertrophic Cardiomyopathy","volume":"18","author":"Mandes","year":"2020","unstructured":". Mandes L, Rosca M, Ciuperca D, Popescu BA. The Role of Echocardiography for Diagnosis and Prognostic Stratification in Hypertrophic Cardiomyopathy. J Echocardiogr. 2020;18(3):137-48. doi: 10.1007\/s12574-020-00467-9.","journal-title":"J Echocardiogr"},{"issue":"6","key":"key20260206194459_B3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","article-title":"Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography","volume":"35","author":"Nagueh","year":"2022","unstructured":". Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A, et al. Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2022;35(6):533-69. doi: 10.1016\/j.echo.2022.03.012.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"key20260206194459_B4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review","volume":"79","author":"Maron","year":"2022","unstructured":". Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):372-89. doi: 10.1016\/j.jacc.2021.12.002.","journal-title":"J Am Coll Cardiol"},{"key":"key20260206194459_B5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2023.04.005","article-title":"How Common is Hypertrophic Cardiomyopathy\u2026 Really?: Disease Prevalence Revisited 27 Years after CARDIA","volume":"382","author":"Massera","year":"2023","unstructured":". Massera D, Sherrid MV, Maron MS, Rowin EJ, Maron BJ. How Common is Hypertrophic Cardiomyopathy\u2026 Really?: Disease Prevalence Revisited 27 Years after CARDIA. Int J Cardiol. 2023;382:64-7. doi: 10.1016\/j.ijcard.2023.04.005.","journal-title":"Int J Cardiol"},{"issue":"4","key":"key20260206194459_B6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults. Echocardiographic Analysis of 4111 Subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","unstructured":". Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults. Echocardiographic Analysis of 4111 Subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92(4):785-9. doi: 10.1161\/01.cir.92.4.785.","journal-title":"Circulation"},{"issue":"12","key":"key20260206194459_B7","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","article-title":"Prevalence of Hypertrophic Cardiomyopathy in a Population-Based Sample of American Indians Aged 51 to 77 Years (the Strong Heart Study)","volume":"93","author":"Maron","year":"2004","unstructured":". Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, et al. Prevalence of Hypertrophic Cardiomyopathy in a Population-Based Sample of American Indians Aged 51 to 77 Years (the Strong Heart Study). Am J Cardiol. 2004;93(12):1510-4. doi: 10.1016\/j.amjcard.2004.03.007.","journal-title":"Am J Cardiol"},{"issue":"1","key":"key20260206194459_B8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","article-title":"Prevalence of Hypertrophic Cardiomyopathy in a Population of Adult Japanese Workers as Detected by Echocardiographic Screening","volume":"59","author":"Hada","year":"1987","unstructured":". Hada Y, Sakamoto T, Amano K, Yamaguchi T, Takenaka K, Takahashi H, et al. Prevalence of Hypertrophic Cardiomyopathy in a Population of Adult Japanese Workers as Detected by Echocardiographic Screening. Am J Cardiol. 1987;59(1):183-4. doi: 10.1016\/s0002-9149(87)80107-8.","journal-title":"Am J Cardiol"},{"issue":"1","key":"key20260206194459_B9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of Idiopathic Hypertrophic Cardiomyopathy in China: A Population-Based Echocardiographic Analysis of 8080 Adults","volume":"116","author":"Zou","year":"2004","unstructured":". Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, et al. Prevalence of Idiopathic Hypertrophic Cardiomyopathy in China: A Population-Based Echocardiographic Analysis of 8080 Adults. Am J Med. 2004;116(1):14-8. doi: 10.1016\/j.amjmed.2003.05.009.","journal-title":"Am J Med"},{"issue":"6","key":"key20260206194459_B10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.rce.2020.01.014","article-title":"Prevalence of Hypertrophic Cardiomyopathy in a Large Sample of the Spanish Working Population","volume":"221","author":"Rodr\u00edguez-Capit\u00e1n","year":"2021","unstructured":". Rodr\u00edguez-Capit\u00e1n J, Fern\u00e1ndez-Meseguer A, M\u00e1rquez-Camas P, Garc\u00eda-Pinilla JM, Calvo-Bonacho E, Garc\u00eda-Margallo T, et al. Prevalence of Hypertrophic Cardiomyopathy in a Large Sample of the Spanish Working Population. Rev Clin Esp. 2021;221(6):315-22. doi: 10.1016\/j.rceng.2020.01.008.","journal-title":"Rev Clin Esp"},{"issue":"5","key":"key20260206194459_B11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196612","article-title":"Prevalence of Clinically Apparent Hypertrophic Cardiomyopathy in Germany-An Analysis of over 5 Million Patients","volume":"13","author":"Husser","year":"2018","unstructured":". Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, et al. Prevalence of Clinically Apparent Hypertrophic Cardiomyopathy in Germany-An Analysis of over 5 Million Patients. PLoS One. 2018;13(5):e0196612. doi: 10.1371\/journal.pone.0196612.","journal-title":"PLoS One"},{"issue":"1","key":"key20260206194459_B12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227012","article-title":"Trends of the Prevalence and Incidence of Hypertrophic Cardiomyopathy in Korea: A Nationwide Population-Based Cohort Study","volume":"15","author":"Moon","year":"2020","unstructured":". Moon I, Lee SY, Kim HK, Han KD, Kwak S, Kim M, et al. Trends of the Prevalence and Incidence of Hypertrophic Cardiomyopathy in Korea: A Nationwide Population-Based Cohort Study. PLoS One. 2020;15(1):e0227012. doi: 10.1371\/journal.pone.0227012.","journal-title":"PLoS One"},{"issue":"1","key":"key20260206194459_B13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20042-9","article-title":"Prevalence, Incidence and Mortality of Hypertrophic Cardiomyopathy Based on a Population Cohort of 21.9 Million in China","volume":"12","author":"Bai","year":"2022","unstructured":". Bai Y, Zheng JP, Lu F, Zhang XL, Sun CP, Guo WH, et al. Prevalence, Incidence and Mortality of Hypertrophic Cardiomyopathy Based on a Population Cohort of 21.9 Million in China. Sci Rep. 2022;12(1):18799. doi: 10.1038\/s41598-022-20042-9.","journal-title":"Sci Rep"},{"issue":"3","key":"key20260206194459_B14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jjcc.2022.09.015","article-title":"Estimating the Prevalence, Clinical Characteristics, and Treatment Patterns of Hypertrophic Cardiomyopathy in Japan: A Nationwide Medical Claims Database Study","volume":"81","author":"Terasaka","year":"2023","unstructured":". Terasaka N, Spanopoulos D, Miyagoshi H, Kubo T, Kitaoka H. Estimating the Prevalence, Clinical Characteristics, and Treatment Patterns of Hypertrophic Cardiomyopathy in Japan: A Nationwide Medical Claims Database Study. J Cardiol. 2023;81(3):316-22. doi: 10.1016\/j.jjcc.2022.09.015.","journal-title":"J Cardiol"},{"issue":"1","key":"key20260206194459_B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4250\/jcu.2015.23.1.20","article-title":"Survival and Clinical Behavior of Hypertrophic Cardiomyopathy in a Latin American Cohort in Contrast to Cohorts from the Developed World","volume":"23","author":"Espinola-Zavaleta","year":"2015","unstructured":". Espinola-Zavaleta N, Vega A, Basto DM, Alcantar-Fern\u00e1ndez AC, Guarner Lans V, Soto ME. Survival and Clinical Behavior of Hypertrophic Cardiomyopathy in a Latin American Cohort in Contrast to Cohorts from the Developed World. J Cardiovasc Ultrasound. 2015;23(1):20-6. doi: 10.4250\/jcu.2015.23.1.20.","journal-title":"J Cardiovasc Ultrasound"},{"issue":"6","key":"key20260206194459_B16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ahj.2004.09.049","article-title":"Benign Outcome in a Long-Term Follow-up of Patients with Hypertrophic Cardiomyopathy in Brazil","volume":"149","author":"Arteaga","year":"2005","unstructured":". Arteaga E, Ianni BM, Fernandes F, Mady C. Benign Outcome in a Long-Term Follow-up of Patients with Hypertrophic Cardiomyopathy in Brazil. Am Heart J. 2005;149(6):1099-105. doi: 10.1016\/j.ahj.2004.09.049.","journal-title":"Am Heart J"},{"issue":"3","key":"key20260206194459_B17","first-page":"257","article-title":"Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study","volume":"107","author":"Mattos","year":"2016","unstructured":". Mattos BP, Scolari FL, Torres MA, Simon L, Freitas VC, Giugliani R, et al. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study. Arq Bras Cardiol. 2016;107(3):257-65. doi: 10.5935\/abc.20160133.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20260206194459_B18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00438-023-02048-8","article-title":"Identification of Variants in Genes Associated with Hypertrophic Cardiomyopathy in Mexican Patients","volume":"298","author":"Garc\u00eda-Vielma","year":"2023","unstructured":". Garc\u00eda-Vielma C, Lazalde-C\u00f3rdova LG, Arzola-Hern\u00e1ndez JC, Gonz\u00e1lez-Aceves EN, L\u00f3pez-Zertuche H, Guzm\u00e1n-Delgado NE, et al. Identification of Variants in Genes Associated with Hypertrophic Cardiomyopathy in Mexican Patients. Mol Genet Genomics. 2023;298(6):1289-99. doi: 10.1007\/s00438-023-02048-8.","journal-title":"Mol Genet Genomics"},{"key":"key20260206194459_B19","first-page":"295","article-title":"Registro Uruguayo de Miocardiopat\u00eda Hipertr\u00f3fica (RUMHI)","volume":"30","author":"Vidal","year":"2015","unstructured":". Vidal DI, Estigarribia J, B\u00e1ez \u00c1, Vidal L. Registro Uruguayo de Miocardiopat\u00eda Hipertr\u00f3fica (RUMHI). Rev Urug Cardiol. 2015;30:295-311.","journal-title":"Rev Urug Cardiol"},{"key":"key20260206194459_B20","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1091269","article-title":"A Review of Ancestrality and Admixture in Latin America and the Caribbean Focusing on Native American and African Descendant Populations","volume":"14","author":"Oliveira","year":"2023","unstructured":". Oliveira TC, Secolin R, Lopes-Cendes I. A Review of Ancestrality and Admixture in Latin America and the Caribbean Focusing on Native American and African Descendant Populations. Front Genet. 2023;14:1091269. doi: 10.3389\/fgene.2023.1091269.","journal-title":"Front Genet"},{"key":"key20260206194459_B21","doi-asserted-by":"crossref","DOI":"10.1186\/1746-4269-9-72","article-title":"The Current Status of Ethnobiological Research in Latin America: Gaps and Perspectives","volume":"9","author":"Albuquerque","year":"2013","unstructured":". Albuquerque UP, Silva JS, Campos JL, Sousa RS, Silva TC, Alves RR. The Current Status of Ethnobiological Research in Latin America: Gaps and Perspectives. J Ethnobiol Ethnomed. 2013;9:72. doi: 10.1186\/1746-4269-9-72.","journal-title":"J Ethnobiol Ethnomed"},{"issue":"1","key":"key20260206194459_B22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ije\/dyu027","article-title":"Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"44","author":"Schmidt","year":"2015","unstructured":". Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2015;44(1):68-75. doi: 10.1093\/ije\/dyu027.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"key20260206194459_B23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/1516-3180.2018.1363070518","article-title":"Launching the Latin American Epidemiological Cooperation Relating to Noncommunicable Diseases","volume":"136","author":"Lotufo","year":"2018","unstructured":". Lotufo PA. Launching the Latin American Epidemiological Cooperation Relating to Noncommunicable Diseases. Sao Paulo Med J. 2018;136(3):189-191. doi: 10.1590\/1516-3180.2018.1363070518.","journal-title":"Sao Paulo Med J"},{"issue":"25","key":"key20260206194459_B24","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","unstructured":". Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, et al. 2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935-59. doi: 10.1016\/j.jacc.2013.11.005.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20260206194459_B25","first-page":"416","article-title":"Electrocardiographic Findings in Brazilian Adults without Heart Disease: ELSA-Brasil","volume":"109","author":"Pinto","year":"2017","unstructured":". Pinto MM Filho, Brant LCC, Padilha-da-Silva JL, Foppa M, Lotufo PA, Mill JG, et al. Electrocardiographic Findings in Brazilian Adults without Heart Disease: ELSA-Brasil. Arq Bras Cardiol. 2017;109(5):416-24. doi: 10.5935\/abc.20170146.","journal-title":"Arq Bras Cardiol"},{"key":"key20260206194459_B26","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-84882-778-3","volume-title":"The Minnesota Code Manual of Electrocardiographic Findings","author":"Prineas","year":"2010","unstructured":". Prineas R, Crow R, Zhang ZM. The Minnesota Code Manual of Electrocardiographic Findings. Berlin: Springer Nature; 2010."},{"issue":"2","key":"key20260206194459_B27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","article-title":"Recommendations for Quantification of Doppler Echocardiography: A Report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography","volume":"15","author":"Qui\u00f1ones","year":"2002","unstructured":". Qui\u00f1ones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for Quantification of Doppler Echocardiography: A Report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167-84. doi: 10.1067\/mje.2002.120202.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"key20260206194459_B28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2023.07.012","article-title":"Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy","volume":"17","author":"Hughes","year":"2024","unstructured":". Hughes RK, Shiwani H, Rosmini S, Augusto JB, Burke L, Jiang Y, et al. Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2024;17(5):501-12. doi: 10.1016\/j.jcmg.2023.07.012.","journal-title":"JACC Cardiovasc Imaging"},{"key":"key20260206194459_B29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4236\/ojs.2021.115047","article-title":"Confidence Intervals for the Binomial Proportion: A Comparison of Four Methods","volume":"11","author":"Orawo","year":"2021","unstructured":". Orawo LA. Confidence Intervals for the Binomial Proportion: A Comparison of Four Methods. Open J Stat. 2021;11:806-16. doi: 10.4236\/ojs.2021.115047.","journal-title":"Open J Stat"},{"issue":"17","key":"key20260206194459_B30","article-title":"Hypertrophic Cardiomyopathy in a Latin American Center: A Single Center Observational Study","volume":"12","author":"Leon","year":"2023","unstructured":". Leon JDLP, Estacio M, Giraldo N, Escalante M, Rodas Y, Largo J, et al. Hypertrophic Cardiomyopathy in a Latin American Center: A Single Center Observational Study. J Clin Med. 2023;12(17):5682. doi: 10.3390\/jcm12175682.","journal-title":"J Clin Med"},{"issue":"7","key":"key20260206194459_B31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","unstructured":". Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017;121(7):749-70. doi: 10.1161\/CIRCRESAHA.117.311059.","journal-title":"Circ Res"},{"issue":"5","key":"key20260206194459_B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers","volume":"76","author":"Lorenzini","year":"2020","unstructured":". Lorenzini M, Norrish G, Field E, Ochoa JP, Cicerchia M, Akhtar MM, et al. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers. J Am Coll Cardiol. 2020;76(5):550-9. doi: 10.1016\/j.jacc.2020.06.011.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20260206194459_B33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007230","article-title":"Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry","volume":"13","author":"Canepa","year":"2020","unstructured":". Canepa M, Fumagalli C, Tini G, Vincent-Tompkins J, Day SM, Ashley EA, et al. Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry. Circ Heart Fail. 2020;13(9):e007230. doi: 10.1161\/CIRCHEARTFAILURE.120.007230.","journal-title":"Circ Heart Fail"},{"key":"key20260206194459_B34","article-title":"Clinical Course of Adults with Co-Occurring Hypertrophic Cardiomyopathy and Hypertension: A Scoping Review","volume":"39","author":"Arabadjian","year":"2024","unstructured":". Arabadjian M, Montgomery S, Pleasure M, Nicolas B, Collins M, Reuter M, et al. Clinical Course of Adults with Co-Occurring Hypertrophic Cardiomyopathy and Hypertension: A Scoping Review. Am Heart J Plus. 2024;39:100367. doi: 10.1016\/j.ahjo.2024.100367.","journal-title":"Am Heart J Plus"},{"issue":"3","key":"key20260206194459_B35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.recesp.2017.05.026","article-title":"Factors Influencing the Phenotypic Expression of Hypertrophic Cardiomyopathy in Genetic Carriers","volume":"71","author":"P\u00e9rez-S\u00e1nchez","year":"2018","unstructured":". P\u00e9rez-S\u00e1nchez I, Romero-Puche AJ, S\u00e1ez EGM, Sabater-Molina M, L\u00f3pez-Ayala JM, Mu\u00f1oz-Esparza C, et al. Factors Influencing the Phenotypic Expression of Hypertrophic Cardiomyopathy in Genetic Carriers. Rev Esp Cardiol. 2018;71(3):146-54. doi:10.1016\/j.recesp.2017.05.026.","journal-title":"Rev Esp Cardiol"},{"issue":"10431","key":"key20260206194459_B36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide Trends in Underweight and Obesity from 1990 to 2022: A Pooled Analysis of 3663 Population-Representative Studies with 222 Million Children, Adolescents, and Adults","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":". NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Underweight and Obesity from 1990 to 2022: A Pooled Analysis of 3663 Population-Representative Studies with 222 Million Children, Adolescents, and Adults. Lancet. 2024;403(10431):1027-50. doi: 10.1016\/S0140-6736(23)02750-2.","journal-title":"Lancet"},{"issue":"4","key":"key20260206194459_B37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7861\/clinmed.2023-0194","article-title":"The Weight of Obesity in Hypertrophic Cardiomyopathy","volume":"23","author":"Zaromytidou","year":"2023","unstructured":". Zaromytidou M, Savvatis K. The Weight of Obesity in Hypertrophic Cardiomyopathy. Clin Med. 2023;23(4):357-63. doi: 10.7861\/clinmed.2023-0194.","journal-title":"Clin Med"},{"issue":"1","key":"key20260206194459_B38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","unstructured":". Fumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, et al. Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy. JAMA Cardiol. 2020;5(1):65-72. doi: 10.1001\/jamacardio.2019.4268.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"key20260206194459_B39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ehjqcco\/qcac006","article-title":"Association between Common Cardiovascular Risk Factors and Clinical Phenotype in Patients with Hypertrophic Cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy\/Myocarditis Registry","volume":"9","author":"Lopes","year":"2022","unstructured":". Lopes LR, Losi MA, Sheikh N, Laroche C, Charron P, Gimeno J, et al. Association between Common Cardiovascular Risk Factors and Clinical Phenotype in Patients with Hypertrophic Cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy\/Myocarditis Registry. Eur Heart J Qual Care Clin Outcomes. 2022;9(1):42-53. doi: 10.1093\/ehjqcco\/qcac006.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"17","key":"key20260206194459_B40","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/2047487319889714","article-title":"Obesity and Metabolic Health Status are Determinants for the Clinical Expression of Hypertrophic Cardiomyopathy","volume":"27","author":"Park","year":"2020","unstructured":". Park JB, Kim DH, Lee H, Hwang IC, Yoon YE, Park HE, et al. Obesity and Metabolic Health Status are Determinants for the Clinical Expression of Hypertrophic Cardiomyopathy. Eur J Prev Cardiol. 2020;27(17):1849-57. doi: 10.1177\/2047487319889714.","journal-title":"Eur J Prev Cardiol"},{"issue":"22","key":"key20260206194459_B41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018641","article-title":"Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier","volume":"9","author":"Nollet","year":"2020","unstructured":". Nollet EE, Westenbrink BD, Boer RA, Kuster DWD, van der Velden J. Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier. J Am Heart Assoc. 2020;9(22):e018641. doi: 10.1161\/JAHA.120.018641.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"key20260206194459_B42","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001560","article-title":"Sarcomere Mutation Negative Hypertrophic Cardiomyopathy is Associated with Ageing and Obesity","volume":"8","author":"Feria","year":"2021","unstructured":". Feria AE, Kott AE, Becker JR. Sarcomere Mutation Negative Hypertrophic Cardiomyopathy is Associated with Ageing and Obesity. Open Heart. 2021;8(1):e001560. doi: 10.1136\/openhrt-2020-001560.","journal-title":"Open Heart"},{"issue":"3","key":"key20260206194459_B43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/ehjci\/jeab217","article-title":"Comparing Echocardiographic Characteristics in Genotype Positive-Phenotype Positive Hypertrophic Cardiomyopathy and Hypertensive Left Ventricular Hypertrophy","volume":"23","author":"de la Rosa","year":"2022","unstructured":". de la Rosa A, Shah M, Shiota T, Siegel R, Rader F. Comparing Echocardiographic Characteristics in Genotype Positive-Phenotype Positive Hypertrophic Cardiomyopathy and Hypertensive Left Ventricular Hypertrophy. Eur Heart J Cardiovasc Imaging. 2022;23(3):340-8. doi: 10.1093\/ehjci\/jeab217.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"14","key":"key20260206194459_B44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/heartjnl-2015-308764","article-title":"Distinguishing Ventricular Septal Bulge versus Hypertrophic Cardiomyopathy in the Elderly","volume":"102","author":"Canepa","year":"2016","unstructured":". Canepa M, Pozios I, Vianello PF, Ameri P, Brunelli C, Ferrucci L, et al. Distinguishing Ventricular Septal Bulge versus Hypertrophic Cardiomyopathy in the Elderly. Heart. 2016;102(14):1087-94. doi: 10.1136\/heartjnl-2015-308764.","journal-title":"Heart"},{"issue":"4","key":"key20260206194459_B45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10741-021-10147-0","article-title":"Deciphering Hypertrophic Cardiomyopathy with Electrocardiography","volume":"27","author":"Gossios","year":"2022","unstructured":". Gossios T, Savvatis K, Zegkos T, Ntelios D, Rouskas P, Parcharidou D, et al. Deciphering Hypertrophic Cardiomyopathy with Electrocardiography. Heart Fail Rev. 2022;27(4):1313-23. doi: 10.1007\/s10741-021-10147-0.","journal-title":"Heart Fail Rev"},{"issue":"9","key":"key20260206194459_B46","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/pace.12913","article-title":"Electrocardiography Screening for Hypertrophic Cardiomyopathy","volume":"39","author":"Campbell","year":"2016","unstructured":". Campbell MJ, Zhou X, Han C, Abrishami H, Webster G, Miyake CY, et al. Electrocardiography Screening for Hypertrophic Cardiomyopathy. Pacing Clin Electrophysiol. 2016;39(9):944-50. doi: 10.1111\/pace.12913.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"20","key":"key20260206194459_B47","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jacc.2022.03.347","article-title":"Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy","volume":"79","author":"Norrish","year":"2022","unstructured":". Norrish G, Cleary A, Field E, Cervi E, Boleti O, Zi\u00f3lkowska L, et al. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2022;79(20):1986-97. doi: 10.1016\/j.jacc.2022.03.347.","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"key20260206194459_B48","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the Management of Cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","unstructured":". Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the Management of Cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. doi: 10.1093\/eurheartj\/ehad194.","journal-title":"Eur Heart J"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:45:11Z","timestamp":1770407111000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/prevalencia-e-caracterizacao-do-fenotipo-de-cardiomiopatia-hipertrofica-avaliado-por-ecocardiografia-em-uma-populacao-adulta-brasileira-o-estudo-elsa-brasil\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,6]]}},"alternative-id":["10.36660\/abc.20250116 10.36660\/abc.20250116i"],"URL":"https:\/\/doi.org\/10.36660\/abc.20250116","relation":{"has-translation":[{"id-type":"doi","id":"10.36660\/abc.20250116i","asserted-by":"object"}]},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"e20250116"}}